Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer

Veterinary Pathology

Volumn 47, Issue 2, 2010, Pages 265-274

  Clemente, M ^a   Perez Alenza M D ^a   Illera, J C ^a   Pena L ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Angiogenesis; Canine; Electron microscopy; Histopathology; Immunohistochemistry; Inflammatory breast cancer; Inflammatory mammary cancer; Vasculogenic mimicry

Indexed keywords

ADENOCARCINOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; ELECTRON MICROSCOPY; EXPERIMENTAL NEOPLASM; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RETROSPECTIVE STUDY; ULTRASTRUCTURE;

ADENOCARCINOMA; ANIMALS; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; MICROSCOPY, ELECTRON; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES;

ANIMALIA; CANIS FAMILIARIS;

EID: 77953982060     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985809353167     Document Type: Article

References (83)

1. Attia-Sobol J., Ferriere JP, Cure H., Kwiatkowski F., Achard JL, Verrelle P., Feillel V., De Latour M., Lafaye C., Deloche C.: Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysis. Eur J Cancer 29A:1081-1088, 1993.
2. Bhati R., Patterson C., Livasy CA, Fan C., Ketelsen D., Hu Z., Reynolds E., Tanner C., Moore DT, Gabrielli F., Perou CM, Klauber-DeMore N.: Molecular characterization of human breast tumor vascular cells. Am J Pathol 172:1381-1390, 2008.
3. Bonnier P., Charpin C., Lejeune C., Romain S., Tubiana N., Beedassy B., Martin PM, Serment H., Piana L.: Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition? Int J Cancer 62:382-385, 1995.
4. Buijs JT, Cleton AM, Smit VT, Lowik CW, Papapoulos SE, Pluijm G.: Prognostic significance of periodic acid-Schiff-positive patterns in primary breast cancer and its lymph node metastases. Breast Cancer Res Treat 84:117-130, 2004.
5. Burri PH, Hlushchuk R., Djonov V.: Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn 231:474-488, 2004.
6. Charafe-Jauffret E., Tarpin C., Viens P., Bertucci F.: Defining the molecular biology of inflammatory breast cancer. Semin Oncol 35:41-50, 2008.
7. Charpin C., Bonnier P., Khouzami A., Vacheret H., Andrac L., Lavaut MN, Allasia C., Piana L.: Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR. Anticancer Res 12:591-597, 1992.
8. Charpin C., Dales JP, Garcia S., Carpentier S., Djemli A., Andrac L., Lavaut MN, Allasia C., Bonnier P.: Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays. Clin Cancer Res 10:5815-5819, 2004.
9. Chen MH, Yip GW, Tse GM, Moriya T., Lui PC, Zin ML, Bay BH, Tan PH: Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters. Mod Pathol 21:1183-1191, 2008.
10. Coomber BL, Denton J., Sylvestre A., Kruth S.: Blood vessel density in canine osteosarcoma. Can J Vet Res 62:199-204, 1998.
11. Costello P., McCann A., Carney DN, Dervan PA: Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 26:1181-1184, 1995.
12. De Boer RH, Allum WH, Ebbs SR, Gui GP, Johnston SR, Sacks NP, Walsh G., Ashley S., Smith IE: Multimodality therapy in inflammatory breast cancer: is there a place for surgery? Ann Oncol 11:1147-1153, 2000.
13. Dome B., Hendrix MJ, Paku S., Tovari J., Timar J.: Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. Am J Pathol 170:1-15, 2007.
14. El-Gohary YM, Metwally G., Saad RS, Robinson MJ, Mesko T., Poppiti RJ: Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol 129:578-586, 2008.
15. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410, 1991.
16. Favier J., Plouin PF, Corvol P., Gasc JM: Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am J Pathol 161:1235-1246, 2002.
17. Ferrara N., Gerber HP, LeCouter J.: The biology of VEGF and its receptors. Nat Med 9:669-676, 2003.
18. Folberg R., Hendrix MJ, Maniotis AJ: Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156:361-381, 2000.
19. Folpe AL, Gown AM: Immunohistochemistry for analysis of soft tissue tumors. In: Soft Tissue Tumors, ed. Weiss SW, Goldblum JR, 4th ed., pp. 199-245. Mosby, Inc., St. Louis, Missouri, 2001.
20. Giordano SH: Update on locally advanced breast cancer. Oncologist 8:521-530, 2003.
21. Giordano SH, Hortobagyi GN: Inflammatory breast cancer: clinical progress and the main problems that must be addressed. Breast Cancer Res 5:284-288, 2003.
22. Gong Y.: Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype. Semin Oncol 35:33-40, 2008.
23. Graham JC, Myers RK: The prognostic significance of angiogenesis in canine mammary tumors. J Vet Intern Med 13:416-418, 1999.
24. Griffey SM, Verstraete FJ, Kraegel SA, Lucroy MD, Madewell BR: Computer-assisted image analysis of intratumoral vessel density in mammary tumors from dogs. Am J Vet Res 59:1238-1242, 1998.
25. Guzman G., Cotler SJ, Lin AY, Maniotis AJ, Folberg R.: A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med 131:1776- 1781, 2007.
26. Hao X., Sun B., Zhang S., Zhao X.: [Microarray study of vasculogenic mimicry in bi-directional differentiation malignant tumor] [In Chinese]. Zhonghua Yi Xue Za Zhi 82:1298-1302, 2002.
27. Hao XS, Sun BC, Zhang SW, Zhao XL: [Correlation between the expression of collgen IV, VEGF and vasculogenic mimicry] [In Chinese]. Zhonghua Zhong Liu Za Zhi 25:524-526, 2003.
28. Hendrix MJ, Seftor EA, Hess AR, Seftor RE: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 3:411-421, 2003.
29. Hendrix MJ, Seftor EA, Seftor RE, Trevor KT: Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 150:483-495, 1997.
30. Holash J., Maisonpierre PC, Compton D., Boland P., Alexander CR, Zagzag D., Yancopoulos GD, Wiegand SJ: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998, 1999.
31. Illera JC, Perez-Alenza MD, Nieto A., Jimenez MA, Silvan G., Dunner S., Pena L.: Steroids and receptors in canine mammary cancer. Steroids 71:541-548, 2006.
32. Jaiyesimi IA, Buzdar AU, Hortobagyi G.: Inflammatory breast cancer: a review. J Clin Oncol 10:1014-1024, 1992.
33. Kim T., Lau J., Erban J.: Lack of uniform diagnostic criteria for inflammatory breast cancer limits interpretation of treatment outcomes: a systematic review. Clin Breast Cancer 7:386-395, 2006.
34. Kleer CG, van Golen KL, Merajver SD: Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Res 2: 423-429, 2000.
35. Kleer CG, van Golen KL, Zhang Y., Wu ZF, Rubin MA, Merajver SD: Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 160:579-584, 2002.
36. Kobayashi H., Shirakawa K., Kawamoto S., Saga T., Sato N., Hiraga A., Watanabe I., Heike Y., Togashi K., Konishi J., Brechbiel MW, Wakasugi H.: Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256). Cancer Res 62:860-866, 2002.
37. Kumar V, Abbas AK, Fausto N, ed.: Robbins and Cotran Pathologic Basis of Disease, 7th ed. Elsevier Saunders, Philadelphia, PA, 2005.
38. Lee YJ, Nagai N., Siar CH, Nakano K., Nagatsuka H., Tsujigiwa H., Roan CH, Gunduz M.: Angioarchitecture of primary oral malignant melanomas. J Histochem Cytochem 50:1555-1562, 2002.
39. Liu C., Huang H., Donate F., Dickinson C., Santucci R., El-Sheikh A., Vessella R., Edgington TS: Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Res 62:5470-5475, 2002.
40. Luong RH, Baer KE, Craft DM, Ettinger SN, Scase TJ, Bergman PJ: Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas. Vet Pathol 43:622-631, 2006.
41. Maiolino P., Papparella S., Restucci B., De Vico G.: Angiogenesis in squamous cell carcinomas of canine skin: an immunohistochemical and quantitative analysis. J Comp Pathol 125:117-121, 2001.
42. Maniotis AJ, Folberg R., Hess A., Seftor EA, Gardner LM, Pe'er J., Trent JM, Meltzer PS, Hendrix MJ: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739-752, 1999.
43. Mason G., Johnson O.: Inflammatory breast cancer: patient advocate view. Semin Oncol 35:87-91, 2008.
44. Misdorp W., Else RW, Hellmen E., Lipscomb TP: Histological Classification of Mammary Tumors of the Dog and the Cat. World Human Organization, Geneva, Switzerland, 1999.
45. Mohammed RA, Green A., El-Shikh S., Paish EC, Ellis IO, Martin SG: Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 96:1092-1100, 2007.
46. Pavlakis K., Messini I., Vrekoussis T., Yiannou P., Keramopoullos D., Louvrou N., Liakakos T., Stathopoulos EN: The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions. BMC Cancer 8:88, 2008.
47. Pena L., Perez-Alenza MD, Rodriguez-Bertos A., Nieto A.: Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases. Breast Cancer Res Treat 78:141-148, 2003.
48. Pena L., Silvan G., Perez-Alenza MD, Nieto A., Illera JC: Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study. J Steroid Biochem Mol Biol 84:211-216, 2003.
49. Perez Alenza MD, Tabanera E., Pena L.: Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J Am Vet Med Assoc 219:1110-1114, 2001.
50. Preziosi R., Sarli G., Paltrinieri M.: Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog. J Comp Pathol 130:143-151, 2004.
51. Ranieri G., Passantino L., Patruno R., Passantino G., Jirillo F., Catino A., Mattioli V., Gadaleta C., Ribatti D.: The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Oncol Rep 10:1189-1193, 2003.
52. Resetkova E.: Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis. Semin Oncol 35:25-32, 2008.
53. Restucci B., De Vico G., Maiolino P.: Evaluation of angiogenesis in canine mammary tumors by quantitative platelet endothelial cell adhesion molecule immunohistochemistry. Vet Pathol 37:297- 301, 2000.
54. Sanchez-Archidona AR, Jimenez MA, Perez-Alenza D., Silvan G., Illera JC, Pena L., Dunner S.: Steroid pathway and oestrone sulphate production in canine inflammatory mammary carcinoma. J Steroid Biochem Mol Biol 104:93-99, 2007.
55. Saxena S., Beena KR, Bansal A., Bhatnagar A.: Emperipolesis in a common breast malignancy: a case report. Acta Cytol 46:883- 886, 2002.
56. Shamoto M.: Emperipolesis of hematopoietic cells in myelocytic leukemia: Electron microscopic and phase contrast microscopic studies. Virchows Arch B Cell Pathol Incl Mol Pathol 35:283- 290, 1981.
57. Sharma N., Seftor RE, Seftor EA, Gruman LM, Heidger PM Jr, Cohen MB, Lubaroff DM, Hendrix MJ: Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50:189- 201, 2002.
58. Shirakawa K., Furuhata S., Watanabe I., Hayase H., Shimizu A., Ikarashi Y., Yoshida T., Terada M., Hashimoto D., Wakasugi H.: Induction of vasculogenesis in breast cancer models. Br J Cancer 87:1454-1461, 2002.
59. 'Shirakawa K., Kobayashi H., Heike Y., Kawamoto S., Brechbiel MW, Kasumi F., Iwanaga T., Konishi F., Terada M., Wakasugi H.: Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res 62:560- 566, 2002.
60. Shirakawa K., Kobayashi H., Sobajima J., Hashimoto D., Shimizu A., Wakasugi H.: Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model. Breast Cancer Res 5:136-139, 2003.
61. Shirakawa K., Shibuya M., Heike Y., Takashima S., Watanabe I., Konishi F., Kasumi F., Goldman CK, Thomas KA, Bett A., Terada M., Wakasugi H.: Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. Int J Cancer 99:344-351, 2002.
62. Shirakawa K., Tsuda H., Heike Y., Kato K., Asada R., Inomata M., Sasaki H., Kasumi F., Yoshimoto M., Iwanaga T., Konishi F., Terada M., Wakasugi H.: Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res 61:445-451, 2001.
63. Shirakawa K., Wakasugi H., Heike Y., Watanabe I., Yamada S., Saito K., Konishi F.: Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 99:821-828, 2002.
64. Singletary SE: Surgical management of inflammatory breast cancer. Semin Oncol 35:72-77, 2008.
65. Singletary SE, Cristofanilli M.: Defining the clinical diagnosis of inflammatory breast cancer. Semin Oncol 35:7-10, 2008.
66. Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE, Hendrix MJ: Molecular determinants of ovarian cancer plasticity. Am J Pathol 158:1279-1288, 2001.
67. Sullivan CA, Ghosh S., Ocal IT, Camp RL, Rimm DL, Chung GG: Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer. Hum Pathol 40:156-165, 2009.
68. Sun B., Zhang S., Zhao X., Zhang W., Hao X.: Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol 25:1609-1614, 2004.
69. Susaneck SJ, Allen TA, Hoopes J., Withrow SJ, Macy DW: Inflammatory mammary carcinoma in the dog. J Am Anim Hosp Assoc 9:971-976, 1983.
70. Tavassoli FA: Inflammatory Carcinoma, Inflitrating Carcinomas: Special Types, 2nd ed. McGraw-Hill, New York, NY, 1999.
71. Taylor G., Meltzer: Inflammatory carcinoma of the breast. Am J Cancer 33:33-49, 1938.
72. Thies A., Mangold U., Moll I., Schumacher U.: PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma. J Pathol 195:537-542, 2001.
73. Thomas PA, Kirschmann DA, Cerhan JR, Folberg R., Seftor EA, Sellers TA, Hendrix MJ: Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res 5:2698-2703, 1999.
74. Ueno NT, Buzdar AU, Singletary SE, Ames FC, McNeese MD, Holmes FA, Theriault RL, Strom EA, Wasaff BJ, Asmar L., Frye D., Hortobagyi GN: Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center. Cancer Chemother Pharmacol 40:321-329, 1997.
75. Uzzan B., Nicolas P., Cucherat M., Perret GY: Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64:2941- 2955, 2004.
76. Van der Auwera I., Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P., Van Marck EA, Dirix LY, Vermeulen PB: Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res 11:7637-7642, 2005.
77. Van der Auwera I., Van Laere SJ, Van den Eynden GG, Benoy I., van Dam P., Colpaert CG, Fox SB, Turley H., Harris AL, Van Marck EA, Vermeulen PB, Dirix LY: Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res 10:7965-7971, 2004.
78. van der Schaft DW, Hillen F., Pauwels P., Kirschmann DA, Castermans K., Egbrink MG, Tran MG, Sciot R., Hauben E., Hogendoorn PC, Delattre O., Maxwell PH, Hendrix MJ, Griffioen AW: Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res 65:11520-11528, 2005.
79. von Beust BR, Suter MM, Summers BA: Factor VIII-related antigen in canine endothelial neoplasms: an immunohistochemical study. Vet Pathol 25:251-255, 1988.
80. Wada T., Yasutomi M., Hashmura K., Kunikata M., Tanaka T., Mori M.: Vimentin expression in benign and malignant lesions in the human mammary gland. Anticancer Res 12:1973-1982, 1992.
81. Warso MA, Maniotis AJ, Chen X., Majumdar D., Patel MK, Shilkaitis A., Gupta TK, Folberg R.: Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma. Clin Cancer Res 7:473-477, 2001.
82. Weibel ER, Palade GE: New Cytoplasmic components in arterial endothelia. J Cell Biol 23:101-112, 1964.
83. Young B., Heath JW: Wheater's: Histología funcional. Texto y atlas en color, 4th ed. Harcourt Brace de España, Madrid, Spain, 2006.